A detailed history of Black Rock Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Black Rock Inc. holds 6,647,297 shares of BPMC stock, worth $599 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,647,297
Previous 6,447,461 3.1%
Holding current value
$599 Million
Previous $612 Million 17.14%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$85.18 - $108.78 $17 Million - $21.7 Million
199,836 Added 3.1%
6,647,297 $716 Million
Q1 2024

May 10, 2024

SELL
$73.17 - $99.79 $10 Million - $13.6 Million
-136,715 Reduced 2.08%
6,447,461 $612 Million
Q4 2023

Feb 13, 2024

SELL
$43.96 - $92.84 $158,607 - $334,966
-3,608 Reduced 0.05%
6,584,176 $607 Million
Q3 2023

Nov 13, 2023

BUY
$46.9 - $66.0 $2.44 Million - $3.44 Million
52,049 Added 0.8%
6,587,784 $331 Million
Q2 2023

Aug 11, 2023

SELL
$42.2 - $66.37 $3.65 Million - $5.75 Million
-86,568 Reduced 1.31%
6,535,735 $413 Million
Q1 2023

May 12, 2023

BUY
$37.97 - $50.0 $13.2 Million - $17.4 Million
347,618 Added 5.54%
6,622,303 $298 Million
Q4 2022

Feb 13, 2023

BUY
$41.06 - $66.48 $21.3 Million - $34.4 Million
518,184 Added 9.0%
6,274,685 $275 Million
Q3 2022

Nov 14, 2022

BUY
$49.93 - $77.7 $23.8 Million - $37 Million
476,743 Added 9.03%
5,756,501 $379 Million
Q2 2022

Aug 12, 2022

SELL
$45.23 - $70.15 $4.68 Million - $7.25 Million
-103,380 Reduced 1.92%
5,279,758 $267 Million
Q1 2022

May 12, 2022

BUY
$54.1 - $110.08 $2.5 Million - $5.09 Million
46,264 Added 0.87%
5,383,138 $344 Million
Q4 2021

Feb 10, 2022

BUY
$94.25 - $115.99 $13.1 Million - $16.1 Million
138,860 Added 2.67%
5,336,874 $572 Million
Q3 2021

Nov 09, 2021

BUY
$80.98 - $109.47 $979,534 - $1.32 Million
12,096 Added 0.23%
5,198,014 $534 Million
Q2 2021

Aug 11, 2021

BUY
$82.78 - $101.0 $429 Million - $524 Million
5,185,918 New
5,185,918 $456 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.38B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.